2m 2m 2m 2m 2m 2m 2m
CRTV MDCL HLD (CELZ)
NASDAQ
$0.63+$0.03 (+4.64%)
Price as of Nov 11, 2026 7:55 PM EST- $4.6MMarket Cap
- -81.23%1-Year Change
- BiotechnologyIndustry
CRTV MDCL HLD (CELZ)
$0.63+$0.03 (+4.64%)
CELZ | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.60 | ||
Change | -$0.01 (-1.80%) | ||
Open | $0.61 | ||
High | $0.65 | ||
Low | $0.60 | ||
Previous Close | $0.61 | ||
Volume | 34,647 | ||
30-Day Average Volume | 108,975 | ||
1-Week Change | -10.75% | ||
1-Month Change | -28.31% | ||
1-Year Change | -81.23% | ||
3-Year Change | -85.89% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 7.6M | ||
Total Assets | $7.3M | ||
Market Cap | $4.6M | ||
Enterprise Value | -$2.3M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$2.7M | ||
Free Cash Flow | -$1.7M | ||
EBIT | -$2.7M | ||
EBITDA | -$2.7M | ||
Net Working Capital | $6.6M | ||
EPS | -$0.40 | ||
Enterprise Value/EBITDA | 1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -2 | ||
PEG | -1 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 06/12/2023 | ||
Earnings & Revenue